Wall Street Analysts See a 219.98% Upside in Syndax (SNDX): Can the Stock Really Move This High?

Core Viewpoint - Syndax Pharmaceuticals (SNDX) shows significant upside potential with a mean price target of $35.23, indicating a 220% increase from the current price of $11.01 [1] Price Targets and Estimates - The mean estimate consists of 13 short-term price targets with a standard deviation of $10.34, suggesting variability among analysts [2] - The lowest estimate of $17 indicates a 54.4% increase, while the highest estimate predicts a surge of 363.2% to $51 [2] - A low standard deviation indicates a high degree of agreement among analysts regarding price movement [9] Analyst Sentiment and Earnings Estimates - Analysts have shown increasing optimism about SNDX's earnings prospects, with a positive trend in earnings estimate revisions [11] - The Zacks Consensus Estimate for the current year has risen by 5.6% over the past month, with four estimates increasing and no negative revisions [12] - SNDX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are commonly referenced, they can mislead investors, as empirical research shows they rarely indicate actual stock price movements [7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]